The popular cholesterol medications Vytorin and Zetia offer few health benefits to patients and do little to treat heart disease — such as thickening of the arteries — according to a study published Sunday in the New England Journal of Medicine (NEJM). A NEJM editorial (also published Sunday) recommends that, until definitive proof of the health benefits of these drugs becomes available, “it seems prudent to encourage patients whose LDL cholesterol levels remain elevated despite treatment wit

More: continued here